Aerovate Therapeutics, Inc. - COM (AVTE)

Historical Portfolio Holders from Q2 2021 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
28.4 M
Holdings value Q1 2024
$840 M
Value change Q1 2024
+$13.2 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
78
Number of buys Q1 2024
40
Number of sells Q1 2024
-26
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
008064107
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 28.4 M $840 M +$13.2 M $29.57 78
2023 Q4 28.1 M $637 M -$810 K $22.63 62
2023 Q3 28.5 M $386 M -$1.3 M $13.57 58
2023 Q2 28.5 M $488 M +$39.1 M $17.15 60
2023 Q1 26 M $524 M -$46.6 M $20.17 65
2022 Q4 27.4 M $803 M +$18.1 M $29.30 67
2022 Q3 27 M $447 M +$20.3 M $16.58 51
2022 Q2 25.8 M $403 M -$2.4 M $15.63 45
2022 Q1 25.9 M $475 M +$8.6 M $18.33 42
2021 Q4 25.6 M $302 M -$15.3 M $11.79 46
2021 Q3 21.7 M $453 M +$35.1 M $20.98 41
2021 Q2 20 M $454 M +$454 M $22.83 17